Journal of the National Cancer Institute

Aims & Scope

The Journal of the National Cancer Institute (print ISSN: 0027-8874, online ISSN: 1460-2105) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment.

For the past several years, the JNCI has been ranked as the most-cited original-research cancer journal by the Institute of Scientific Information in its annual Journal Citation Reports.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	7.2
2024	9.90

SJR (SCImago Journal Rank)

Year	Value
2024	5.703

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	394

Journal Rank

Year	Value
2024	234

Journal Citation Indicator

Year	Value
2024	4822

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• New Guidelines to Evaluate the Response to Treatment in Solid Tumors

  Citation: 13318

  Authors: Patrick, Susan G., Elizabeth A., Jantien, Richard S., Larry, Jaap, Martine, Allan T., Michaele C., Steve G.

• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

  Citation: 12450

  Authors: N. K., S., B., M., A., N. J., A., H., S. B., J. C. J. M. d., S., M., D., D., P. B., S., K., M., F.

• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

  Citation: 8034

  Authors: P., R., D., A., J., D., J. T., H., S., M. R.

• Photodynamic Therapy

  Citation: 4487

  Authors: T. J., C. J., B. W., G., D., M., J., Q.

• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

  Citation: 4289

  Authors: Bernard, Joseph P., D. Lawrence, Carol K., Maureen, Walter M., Victor, André, Nikolay, James, Mary, Samuel, Elizabeth, Leslie, Norman

• What Is the Evidence That Tumors Are Angiogenesis Dependent?

  Citation: 3463

  Authors: Judah

• The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

  Citation: 3373

  Authors: Richard, Richard

• Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

  Citation: 2717

  Authors: A., D., P., R., K., D., C., J., P., A., M., H., J., M.

• Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

  Citation: 2607

  Authors: M. H., L. A., D. P., D. K., S. B., C., J. J.

• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  Citation: 2494

  Authors: F. X., M. M., N., M., A. M., J., M. H., V., R., K. V.

---